Tech Company Financing Transactions
VitaDAO Funding Round
Pfizer Venture Investments, private investors and L1 Digital joined a $4.1 million funding round for VitaDAO. This venture round was announced on 1/30/2023.
Transaction Overview
Company Name
Announced On
1/30/2023
Transaction Type
Venture Equity
Amount
$4,100,000
Round
Undisclosed
Investors
Pfizer Venture Investments (Lead Investor)
private investors (Balaji Srinivasan)
Proceeds Purpose
VitaDAO is part of a nascent movement known as decentralized science (DeSci). In place of the current science ecosystem that relies on centralized bodies of research and funding, DeSci aims to source funding for research through crowdfunding and to decentralize ownership.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Berlin, Undisclosed
DE
Berlin, Undisclosed
DE
Phone
Undisclosed
Website
Email Address
Overview
VitaDAO is a DAO collective for community-governed and decentralized drug development. Our core mission is the acceleration of research and development (R&D) in the longevity space and the extension of human life and healthspan. To achieve this, VitaDAO collectively funds and digitizes research in the form of IP-NFTs, and spins out new biotech companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Tyler Golato
Browse more venture capital transactions:
Prev: 1/30/2023: Caura venture capital transaction
Next: 1/30/2023: Lemu venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs